Follow
Christopher McChalicher
Christopher McChalicher
Vice President, Technology Development
Verified email at serestherapeutics.com
Title
Cited by
Cited by
Year
Handbook of hydrocarbon and lipid microbiology
T McGenity, JR Van Der Meer, V de Lorenzo
Springer, 2010
5652010
Bacterial synthesis of PHA block copolymers
EN Pederson, CWJ McChalicher, F Srienc
Biomacromolecules 7 (6), 1904-1911, 2006
1332006
Physical and chemical changes in feather keratin during pyrolysis
E Senoz, RP Wool, CWJ McChalicher, CK Hong
Polymer Degradation and Stability 97 (3), 297-307, 2012
922012
Investigating the structure–property relationship of bacterial PHA block copolymers
CWJ McChalicher, F Srienc
Journal of biotechnology 132 (3), 296-302, 2007
822007
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial
BH McGovern, CB Ford, MR Henn, DS Pardi, S Khanna, EL Hohmann, ...
Clinical infectious diseases 72 (12), 2132-2140, 2021
612021
Solubility and degradation of polyhydroxyalkanoate biopolymers in propylene carbonate
CWJ McChalicher, F Srienc, DP Rouse
AIChE journal 56 (6), 1616-1625, 2010
412010
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
P Feuerstadt, TJ Louie, B Lashner, EEL Wang, L Diao, JA Bryant, M Sims, ...
New England Journal of Medicine 386 (3), 220-229, 2022
282022
RENEWABLE ACRYLIC ACID PRODUCTION AND PRODUCTS MADE THEREFROM
S HARRIS, KA SPARKS, OP PEOPLES, Y SHABTAI, ...
WO Patent App. PCT/US2013/044,671, 2013
15*2013
Increased yields of phas from hydrogen feeding and diverse carbon fixation pathways
TM Ramseier, CWJ McChalicher
US Patent App. 13/830,296, 2013
52013
Green process for producing polyhydroxyalkanoates and chemicals using a renewable feedstock
Z Zhang, CWJ McChalicher, J Van Walsem, OP Peoples, RP Eno, ...
US Patent 9,663,791, 2017
32017
Fr572 24-WEEK EFFICACY AND SAFETY DATA FROM ECOSPOR-III, A PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED RANDOMIZED TRIAL OF SER-109, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC FOR …
L Korman, B Lashner, C Kraft, M Sims, EE Wang, K Brady, CB Ford, ...
Gastroenterology 160 (6), S-368-S-369, 2021
22021
Genetically Engineered Microorganisms for the Production of Poly-4-Hydroxybutyrate
TM Ramseier, CWJ McChalicher, WR Farmer, Z Zhang, DE Chang, ...
US Patent App. 14/386,728, 2015
22015
Microbiome product manufacture out of a SU facility set up
C McChalicher, D Ege
2022
1035. Manufacturing Processes of SER-109, a Purified Investigational Microbiome Therapeutic, Reduce Risk of Transmission of Emerging and Undetected Infections in Donor Stool
C McChalicher, A Abdulaziz, E Halvorsen, MJ Lombardo, J Winkler, ...
Open Forum Infectious Diseases 8 (Supplement_1), S607-S608, 2021
2021
Efficacy and Safety of Investigational Microbiome Drug SER-109 for Treatment of Recurrent Clostridioides difficile Infection
B McGovern, M Sims, C Kraft, E Wang, K Brady, C Ford, MJ Lombardo, ...
Antimicrobial Stewardship & Healthcare Epidemiology 1 (S1), s5-s5, 2021
2021
99 Engineering Monomer Composition of PHA Accumulated in Yeast
CWJMCF Srienc
2010
POLY 466-Synthesis of mixed class polyhydroxyalkanoates using a mutated synthase enzyme
CWJ McChalicher, F Srienc
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 238, 2009
2009
Synthesis of PHA block-copolymers with bacteria
C McChalicher, F Srienc
2007
Computer chips, houses and low-cost carbon fibers from chicken feathers and soybeans.
RP Wool, CK Hong, CW McChalicher
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 228, U247-U247, 2004
2004
IDWEEK 2021 Poster# 1035
C McChalicher, A Abdulaziz, E Halvorsen, MJ Lombardo, J Winkler, ...
The system can't perform the operation now. Try again later.
Articles 1–20